NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
20.39
+0.38 (1.90%)
Nov 21, 2024, 12:49 PM EST - Market open
NAMS Market Cap
NAMS has a market cap or net worth of $1.88 billion as of November 21, 2024. Its market cap has increased by 124.33% in one year.
Market Cap
1.88B
Enterprise Value
1.43B
1-Year Change
124.33%
Ranking
Category
Stock Price
$20.39
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $1.88B, an increase of 1,119.65%. That is a compound annual growth rate of 93.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 1.85B | 101.03% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | 154.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| iRhythm Technologies | 2.41B |
| Arrowhead Pharmaceuticals | 2.36B |
| Longboard Pharmaceuticals | 2.33B |
| LeMaitre Vascular | 2.33B |
| Geron | 2.29B |
| IDEAYA Biosciences | 2.26B |
| CG Oncology | 2.25B |
| Soleno Therapeutics | 2.23B |